Scholars Central

Conference abstractPublished 4 Jun 2018

Therapeutic potential for somatic neural stem cell (nsc) grafts in the restoration of midbrain dopaminergic neuronal function in the aged parkinsonian brain

Authors: Bianca Marchetti

University of Catania Medical School, Italy.

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Parkinson’s disease (PD) is the most prevalent central nervous system (CNS) movement disorder characterized by the progressive loss of midbrain dopaminergic (mDA) neurons of the substantia nigra pars compacta (SNpc). The causes and mechanisms leading to mDA neuron demise in sporadic PD remain poorly understood, but current evidence indicates that they depend on a complex interaction of genetic susceptibility, environmental factors and, most importantly, aging and inflammation. Particularly, reactive astrocytes (Ras) are key players in the response to PD injury and inflammation, via Wnt/β-catenin signalling, regulating both helpful and harmful responses. Because aging is the chief risk factor for PD development, we focused on the aged male midbrain microenvironment to address the ability of neural stem progenitor cells (NSCs) to activate intrinsic cues that may instruct midbrain astrocytes to implement mDA neurorepair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced long-lasting DA neurotoxicity. Here, we discuss our recent data showing that subventricular zone (SVZ)-derived adult NSCs transplanted in the aged MPTP-injured SNpc promote a remarkable time-dependent endogenous nigrostriatal DA neurorestoration. Although multiple modes of reciprocal interactions between exogenous NSCs and the pathological host milieu may underlie the functional improvement observed, our data suggest that NSCs and astrocyte-derived factors, especially Wnt1, might play a major role acting at different levels to rejuvenate the host microenvironment and promote mDA neurorepair/regeneration. In light of the emerging picture implicating deregulated Wnt/β-catenin signalling in PD, our findings predict a novel perspective on harnessing Wnt/β-catenin signalling with functionally plastic NSC grafts as a novel therapeutic strategy for PD

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Bianca Marchetti”